ESSA Pharma Ownership 2024 | Who Owns ESSA Pharma Now?
Institutional Ownership
79.59%
Insider Ownership
2.27%
Retail Ownership
18.14%
Institutional Holders
34.00
ESSA Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BVF INC/IL | 19.78% | 1.29% | 8,748,629 | - | - | 46,017,788 | Jun 30, 2024 |
BELLEVUE GROUP AG | 17.83% | 0.67% | 7,889,583 | - | - | 41,499,207 | Jun 30, 2024 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 9.52% | 1.95% | 4,210,537 | 620,979 | 17.30% | 22,147,425 | Jun 30, 2024 |
MORGAN STANLEY | 9.44% | 0.00% | 4,177,848 | -700 | -0.02% | 21,975,480 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 6.70% | 0.77% | 2,965,442 | -14,978 | -0.50% | 15,598,225 | Jun 30, 2024 |
RTW INVESTMENTS, LP | 5.20% | 0.19% | 2,298,662 | - | - | 12,090,962 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.33% | 0.01% | 1,474,165 | -106,210 | -6.72% | 7,754,108 | Jun 30, 2024 |
JANUS HENDERSON GROUP PLC | 2.27% | 0.00% | 1,006,202 | -169,040 | -14.38% | 5,192,002 | Jun 30, 2024 |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.82% | 0.41% | 806,054 | -105,766 | -11.60% | 4,239,844 | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.11% | 677,005 | - | - | 3,561,046 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.71% | 0.01% | 315,736 | -52,764 | -14.32% | 1,660,771 | Jun 30, 2024 |
PARKMAN HEALTHCARE PARTNERS LLC | 0.57% | 0.18% | 252,072 | 377 | 0.15% | 1,325,899 | Jun 30, 2024 |
CIBC WORLD MARKET INC. | 0.18% | 0.00% | 80,257 | -600 | -0.74% | 422,000 | Jun 30, 2024 |
D. E. SHAW & CO., INC. | 0.14% | 0.00% | 63,481 | -1,600 | -2.46% | 333,910 | Jun 30, 2024 |
AMERICAN CENTURY COMPANIES INC | 0.11% | 0.00% | 46,748 | 572 | 1.24% | 245,894 | Jun 30, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.10% | 0.00% | 43,595 | 1,100 | 2.59% | 229,310 | Jun 30, 2024 |
ROYAL BANK OF CANADA | 0.08% | - | 36,312 | 5,537 | 17.99% | 191,000 | Jun 30, 2024 |
KENNEDY CAPITAL MANAGEMENT LLC | 0.08% | 0.00% | 34,465 | 34,465 | 100.00% | 181,286 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 26,858 | - | - | 141,273 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 10,313 | 10,313 | 100.00% | 54,246 | Jun 30, 2024 |
ESSA Pharma's largest institutional shareholder is BVF INC/IL, holding 19.78% of the company's total share outstanding, currently valued at $46.02M. The top 10 institutional shareholders own together 77.43% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. | 9.52% | 1.95% | 4,210,537 | 620,979 | 17.30% | 22,147,425 | Jun 30, 2024 |
BVF INC/IL | 19.78% | 1.29% | 8,748,629 | - | - | 46,017,788 | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 6.70% | 0.77% | 2,965,442 | -14,978 | -0.50% | 15,598,225 | Jun 30, 2024 |
BELLEVUE GROUP AG | 17.83% | 0.67% | 7,889,583 | - | - | 41,499,207 | Jun 30, 2024 |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.82% | 0.41% | 806,054 | -105,766 | -11.60% | 4,239,844 | Jun 30, 2024 |
RTW INVESTMENTS, LP | 5.20% | 0.19% | 2,298,662 | - | - | 12,090,962 | Jun 30, 2024 |
PARKMAN HEALTHCARE PARTNERS LLC | 0.57% | 0.18% | 252,072 | 377 | 0.15% | 1,325,899 | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.11% | 677,005 | - | - | 3,561,046 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.33% | 0.01% | 1,474,165 | -106,210 | -6.72% | 7,754,108 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.71% | 0.01% | 315,736 | -52,764 | -14.32% | 1,660,771 | Jun 30, 2024 |
KENNEDY CAPITAL MANAGEMENT LLC | 0.08% | 0.00% | 34,465 | 34,465 | 100.00% | 181,286 | Jun 30, 2024 |
JANUS HENDERSON GROUP PLC | 2.27% | 0.00% | 1,006,202 | -169,040 | -14.38% | 5,192,002 | Jun 30, 2024 |
MORGAN STANLEY | 9.44% | 0.00% | 4,177,848 | -700 | -0.02% | 21,975,480 | Jun 30, 2024 |
CIBC WORLD MARKET INC. | 0.18% | 0.00% | 80,257 | -600 | -0.74% | 422,000 | Jun 30, 2024 |
LAUREL WEALTH ADVISORS LLC | 0.00% | 0.00% | 600 | - | - | 3,156 | Jun 30, 2024 |
D. E. SHAW & CO., INC. | 0.14% | 0.00% | 63,481 | -1,600 | -2.46% | 333,910 | Jun 30, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.10% | 0.00% | 43,595 | 1,100 | 2.59% | 229,310 | Jun 30, 2024 |
AMERICAN CENTURY COMPANIES INC | 0.11% | 0.00% | 46,748 | 572 | 1.24% | 245,894 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 10,313 | 10,313 | 100.00% | 54,246 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,000 | - | - | 31,560 | Jun 30, 2024 |
The largest ESSA Pharma shareholder by % of total assets is SOLEUS CAPITAL MANAGEMENT, L.P.. The company owns 4.21M shares of ESSA Pharma (EPIX), representing 1.95% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SOLEUS CAPITAL MANAGEMENT, L.P. | 9.52% | 1.95% | 4,210,537 | 620,979 | 17.30% | 22,147,425 | Jun 30, 2024 |
KENNEDY CAPITAL MANAGEMENT LLC | 0.08% | 0.00% | 34,465 | 34,465 | 100.00% | 181,286 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 10,313 | 10,313 | 100.00% | 54,246 | Jun 30, 2024 |
ROYAL BANK OF CANADA | 0.08% | - | 36,312 | 5,537 | 17.99% | 191,000 | Jun 30, 2024 |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.00% | 0.00% | 2,050 | 2,000 | 4000.00% | 10,783 | Jun 30, 2024 |
BNP PARIBAS ARBITRAGE, SNC | 0.10% | 0.00% | 43,595 | 1,100 | 2.59% | 229,310 | Jun 30, 2024 |
AMERICAN CENTURY COMPANIES INC | 0.11% | 0.00% | 46,748 | 572 | 1.24% | 245,894 | Jun 30, 2024 |
PARKMAN HEALTHCARE PARTNERS LLC | 0.57% | 0.18% | 252,072 | 377 | 0.15% | 1,325,899 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | - | - | 8 | - | - | 42 | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | 21 | - | - | 110 | Jun 30, 2024 |
TORONTO DOMINION BANK | 0.00% | - | 48 | - | - | 252 | Jun 30, 2024 |
BLACKROCK INC. | 0.01% | - | 5,609 | - | - | 29,503 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.06% | - | 26,858 | - | - | 141,273 | Jun 30, 2024 |
CIBC PRIVATE WEALTH GROUP, LLC | 0.01% | - | 2,500 | - | - | 12,900 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.00% | 0.00% | 900 | - | - | 9,849 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,000 | - | - | 31,560 | Jun 30, 2024 |
LAUREL WEALTH ADVISORS LLC | 0.00% | 0.00% | 600 | - | - | 3,156 | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.11% | 677,005 | - | - | 3,561,046 | Jun 30, 2024 |
RTW INVESTMENTS, LP | 5.20% | 0.19% | 2,298,662 | - | - | 12,090,962 | Jun 30, 2024 |
BELLEVUE GROUP AG | 17.83% | 0.67% | 7,889,583 | - | - | 41,499,207 | Jun 30, 2024 |
As of Jun 30 2024, ESSA Pharma's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 620.98K stocks of EPIX, valued at $22.15M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC | 2.27% | 0.00% | 1,006,202 | -169,040 | -14.38% | 5,192,002 | Jun 30, 2024 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.33% | 0.01% | 1,474,165 | -106,210 | -6.72% | 7,754,108 | Jun 30, 2024 |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 1.82% | 0.41% | 806,054 | -105,766 | -11.60% | 4,239,844 | Jun 30, 2024 |
SCHONFELD STRATEGIC ADVISORS LLC | 0.71% | 0.01% | 315,736 | -52,764 | -14.32% | 1,660,771 | Jun 30, 2024 |
TUCKER ASSET MANAGEMENT LLC | - | - | - | -16,097 | -100.00% | - | Jun 30, 2024 |
PFM HEALTH SCIENCES, LP | 6.70% | 0.77% | 2,965,442 | -14,978 | -0.50% | 15,598,225 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -14,052 | -100.00% | - | Jun 30, 2024 |
ENTRYPOINT CAPITAL, LLC | - | - | - | -4,420 | -100.00% | - | Jun 30, 2024 |
SIMPLEX TRADING, LLC | - | - | - | -4,329 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | 0.00% | - | 1,565 | -2,061 | -56.84% | 8,232 | Jun 30, 2024 |
D. E. SHAW & CO., INC. | 0.14% | 0.00% | 63,481 | -1,600 | -2.46% | 333,910 | Jun 30, 2024 |
MORGAN STANLEY | 9.44% | 0.00% | 4,177,848 | -700 | -0.02% | 21,975,480 | Jun 30, 2024 |
CIBC WORLD MARKET INC. | 0.18% | 0.00% | 80,257 | -600 | -0.74% | 422,000 | Jun 30, 2024 |
BVF INC/IL | 19.78% | 1.29% | 8,748,629 | - | - | 46,017,788 | Jun 30, 2024 |
BELLEVUE GROUP AG | 17.83% | 0.67% | 7,889,583 | - | - | 41,499,207 | Jun 30, 2024 |
RTW INVESTMENTS, LP | 5.20% | 0.19% | 2,298,662 | - | - | 12,090,962 | Jun 30, 2024 |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.53% | 0.11% | 677,005 | - | - | 3,561,046 | Jun 30, 2024 |
LAUREL WEALTH ADVISORS LLC | 0.00% | 0.00% | 600 | - | - | 3,156 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | 0.00% | 6,000 | - | - | 31,560 | Jun 30, 2024 |
TD WATERHOUSE CANADA INC. | 0.00% | 0.00% | 900 | - | - | 9,849 | Jun 30, 2024 |
As of Jun 30 2024, ESSA Pharma's biggest institutional seller is JANUS HENDERSON GROUP PLC. The company sold -0.17M shares of EPIX, valued at $5.19M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
KENNEDY CAPITAL MANAGEMENT LLC | 0.08% | 0.00% | 34,465 | 34,465 | 100.00% | 181,286 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.02% | 0.00% | 10,313 | 10,313 | 100.00% | 54,246 | Jun 30, 2024 |
ESSA Pharma's largest new institutional shareholder by number of shares is KENNEDY CAPITAL MANAGEMENT LLC, purchased 34.47K shares, valued at $181.29K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TUCKER ASSET MANAGEMENT LLC | - | - | - | -16,097 | -100.00% | - | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -14,052 | -100.00% | - | Jun 30, 2024 |
ENTRYPOINT CAPITAL, LLC | - | - | - | -4,420 | -100.00% | - | Jun 30, 2024 |
SIMPLEX TRADING, LLC | - | - | - | -4,329 | -100.00% | - | Jun 30, 2024 |
ESSA Pharma's largest sold out institutional shareholder by shares sold is TUCKER ASSET MANAGEMENT LLC, sold -16.10K shares, valued at -, as of undefined.
ESSA Pharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
ETFis Series Trust I | 0.01% | 12,885 | - | - | Jan 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.01% | 371,150 | - | - | Feb 29, 2024 |
DRIEHAUS MUTUAL FUNDS | 0.01% | 51,349 | - | - | Mar 28, 2024 |
Nushares ETF Trust | 0.00% | 29,624 | - | - | Jan 31, 2024 |
VANGUARD HORIZON FUNDS | 0.00% | 59,917 | - | - | Mar 31, 2024 |
JANUS INVESTMENT FUND | 0.00% | 783,841 | - | - | Dec 31, 2023 |
ALPS ETF Trust | 0.00% | 27,865 | - | - | Feb 29, 2024 |
Brinker Capital Destinations Trust | 0.00% | 58,082 | - | - | Feb 29, 2024 |
FIDELITY COVINGTON TRUST | 0.00% | 10,426 | - | - | Jan 31, 2024 |
PENN SERIES FUNDS INC | 0.00% | 16,385 | - | - | Mar 28, 2024 |
MUTUAL FUND SERIES TRUST | 0.00% | 1,561,251 | - | - | Mar 31, 2024 |
OLD WESTBURY FUNDS INC | 0.00% | 44,648 | - | - | Jan 31, 2024 |
VANGUARD WORLD FUND | 0.00% | 73,307 | - | - | Feb 29, 2024 |
RBB FUND, INC. | 0.00% | 24,520 | - | - | Feb 29, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 25,101 | 18,219 | 264.73% | Feb 29, 2024 |
ARTISAN PARTNERS FUNDS INC | 0.00% | 197,335 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 26,858 | - | - | Feb 29, 2024 |
SPDR INDEX SHARES FUNDS | 0.00% | 24,632 | - | - | Mar 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 562 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 4,323 | - | - | Mar 28, 2024 |
FundVantage Trust | 0.00% | 195 | - | - | Mar 28, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 800 | - | - | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 1,866 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 32,540 | - | - | Mar 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 180 | - | - | Jan 31, 2024 |
ESSA Pharma's largest mutual fund holder by % of total assets is "ETFis Series Trust I", owning 12.88K shares, compromising 0.01% of its total assets.
ESSA Pharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 34 | -8.11% |
31 Mar, 24 | 37 | 5.71% |
31 Dec, 23 | 35 | -10.26% |
30 Sep, 23 | 39 | -9.30% |
30 Jun, 23 | 43 | 7.50% |
31 Mar, 23 | 40 | -14.89% |
31 Dec, 22 | 47 | -7.84% |
30 Sep, 22 | 51 | -8.93% |
30 Jun, 22 | 56 | -18.84% |
31 Mar, 22 | 69 | 16.95% |
31 Dec, 21 | 59 | -20.27% |
30 Sep, 21 | 74 | -3.90% |
30 Jun, 21 | 77 | 14.93% |
31 Mar, 21 | 67 | 81.08% |
31 Dec, 20 | 37 | 15.63% |
30 Sep, 20 | 32 | 77.78% |
30 Jun, 20 | 18 | 28.57% |
31 Mar, 20 | 14 | -17.65% |
31 Dec, 19 | 17 | 41.67% |
30 Sep, 19 | 12 | 71.43% |
30 Jun, 19 | 7 | - |
31 Mar, 19 | 7 | - |
31 Dec, 18 | 7 | - |
30 Sep, 18 | 7 | - |
30 Jun, 18 | 7 | - |
As of 30 Jun 24, 34 institutions are holding ESSA Pharma's shares, representing a decrease of -8.11% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 35,208,390 | 0.49% |
31 Mar, 24 | 35,037,057 | 0.76% |
31 Dec, 23 | 34,772,388 | 3.89% |
30 Sep, 23 | 33,469,182 | 0.60% |
30 Jun, 23 | 33,269,455 | 0.54% |
31 Mar, 23 | 33,092,172 | -0.83% |
31 Dec, 22 | 33,368,838 | -1.26% |
30 Sep, 22 | 33,793,965 | -10.54% |
30 Jun, 22 | 37,774,137 | 1.55% |
31 Mar, 22 | 37,197,582 | -0.37% |
31 Dec, 21 | 37,334,765 | 0.43% |
30 Sep, 21 | 37,173,985 | 8.93% |
30 Jun, 21 | 34,126,760 | 10.78% |
31 Mar, 21 | 30,804,832 | 33.42% |
31 Dec, 20 | 23,088,411 | 13.80% |
30 Sep, 20 | 20,288,041 | 44.53% |
30 Jun, 20 | 14,037,155 | -1.34% |
31 Mar, 20 | 14,228,404 | 2.30% |
31 Dec, 19 | 13,908,596 | 13.60% |
30 Sep, 19 | 12,243,635 | 123.37% |
30 Jun, 19 | 5,481,234 | 43.16% |
31 Mar, 19 | 3,828,813 | 0.00% |
31 Dec, 18 | 3,828,750 | 0.10% |
30 Sep, 18 | 3,825,113 | 39.11% |
30 Jun, 18 | 2,749,682 | - |
ESSA Pharma (EPIX) has 35.21M shares outstanding as of 30 Jun 24, up 0.49% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 79.59% | 1.26% |
31 Mar, 24 | 79.40% | 1.28% |
31 Dec, 23 | 78.80% | 1.37% |
30 Sep, 23 | 75.91% | 1.33% |
30 Jun, 23 | 75.45% | 1.34% |
31 Mar, 23 | 75.05% | 1.31% |
31 Dec, 22 | 75.71% | 1.29% |
30 Sep, 22 | 76.74% | 1.04% |
30 Jun, 22 | 85.73% | 1.20% |
31 Mar, 22 | 84.48% | 1.17% |
31 Dec, 21 | 84.87% | 1.03% |
30 Sep, 21 | 90.63% | 1.31% |
30 Jun, 21 | 83.20% | 1.17% |
31 Mar, 21 | 84.43% | 1.76% |
31 Dec, 20 | 69.24% | 1.26% |
30 Sep, 20 | 74.22% | 1.63% |
30 Jun, 20 | 67.41% | 1.44% |
31 Mar, 20 | 68.34% | 1.52% |
31 Dec, 19 | 66.99% | 0.96% |
30 Sep, 19 | 83.49% | 5.98% |
30 Jun, 19 | 37.38% | 5.48% |
31 Mar, 19 | 26.11% | 3.83% |
31 Dec, 18 | 26.11% | 3.84% |
30 Sep, 18 | 26.08% | 7.42% |
30 Jun, 18 | 18.75% | - |
As of 30 Jun 24, ESSA Pharma is held by 79.59% institutional shareholders, representing a 1.26% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 8 | -33.33% |
31 Mar, 24 | 12 | -20.00% |
31 Dec, 23 | 15 | 25.00% |
30 Sep, 23 | 12 | 20.00% |
30 Jun, 23 | 10 | -41.18% |
31 Mar, 23 | 17 | -10.53% |
31 Dec, 22 | 19 | -17.39% |
30 Sep, 22 | 23 | 35.29% |
30 Jun, 22 | 17 | -59.52% |
31 Mar, 22 | 42 | 35.48% |
31 Dec, 21 | 31 | -27.91% |
30 Sep, 21 | 43 | 7.50% |
30 Jun, 21 | 40 | -27.27% |
31 Mar, 21 | 55 | 161.90% |
31 Dec, 20 | 21 | -12.50% |
30 Sep, 20 | 24 | 200.00% |
30 Jun, 20 | 8 | 100.00% |
31 Mar, 20 | 4 | -33.33% |
31 Dec, 19 | 6 | -40.00% |
30 Sep, 19 | 10 | 400.00% |
30 Jun, 19 | 2 | - |
31 Mar, 19 | 2 | -33.33% |
31 Dec, 18 | 3 | -25.00% |
30 Sep, 18 | 4 | -42.86% |
30 Jun, 18 | 7 | - |
8 institutional shareholders have increased their position in EPIX stock as of 30 Jun 24 compared to 12 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 11 | 10.00% |
31 Mar, 24 | 10 | 66.67% |
31 Dec, 23 | 6 | -40.00% |
30 Sep, 23 | 10 | -16.67% |
30 Jun, 23 | 12 | 50.00% |
31 Mar, 23 | 8 | -52.94% |
31 Dec, 22 | 17 | 21.43% |
30 Sep, 22 | 14 | -33.33% |
30 Jun, 22 | 21 | 50.00% |
31 Mar, 22 | 14 | -26.32% |
31 Dec, 21 | 19 | - |
30 Sep, 21 | 19 | -9.52% |
30 Jun, 21 | 21 | 162.50% |
31 Mar, 21 | 8 | -11.11% |
31 Dec, 20 | 9 | 125.00% |
30 Sep, 20 | 4 | - |
30 Jun, 20 | 4 | - |
31 Mar, 20 | 4 | 300.00% |
31 Dec, 19 | 1 | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 1 | - |
31 Mar, 19 | - | -100.00% |
31 Dec, 18 | 1 | - |
30 Sep, 18 | 1 | - |
30 Jun, 18 | - | - |
11 institutional shareholders have reduced their position in EPIX stock as of 30 Jun 24 compared to 10 in the previous quarter (a 10.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 34 | -8.11% | 35,208,390 | 0.49% | 79.59% | 1.26% | 8 | -33.33% | 11 | 10.00% |
31 Mar, 24 | 37 | 5.71% | 35,037,057 | 0.76% | 79.40% | 1.28% | 12 | -20.00% | 10 | 66.67% |
31 Dec, 23 | 35 | -10.26% | 34,772,388 | 3.89% | 78.80% | 1.37% | 15 | 25.00% | 6 | -40.00% |
30 Sep, 23 | 39 | -9.30% | 33,469,182 | 0.60% | 75.91% | 1.33% | 12 | 20.00% | 10 | -16.67% |
30 Jun, 23 | 43 | 7.50% | 33,269,455 | 0.54% | 75.45% | 1.34% | 10 | -41.18% | 12 | 50.00% |
31 Mar, 23 | 40 | -14.89% | 33,092,172 | -0.83% | 75.05% | 1.31% | 17 | -10.53% | 8 | -52.94% |
31 Dec, 22 | 47 | -7.84% | 33,368,838 | -1.26% | 75.71% | 1.29% | 19 | -17.39% | 17 | 21.43% |
30 Sep, 22 | 51 | -8.93% | 33,793,965 | -10.54% | 76.74% | 1.04% | 23 | 35.29% | 14 | -33.33% |
30 Jun, 22 | 56 | -18.84% | 37,774,137 | 1.55% | 85.73% | 1.20% | 17 | -59.52% | 21 | 50.00% |
31 Mar, 22 | 69 | 16.95% | 37,197,582 | -0.37% | 84.48% | 1.17% | 42 | 35.48% | 14 | -26.32% |
31 Dec, 21 | 59 | -20.27% | 37,334,765 | 0.43% | 84.87% | 1.03% | 31 | -27.91% | 19 | - |
30 Sep, 21 | 74 | -3.90% | 37,173,985 | 8.93% | 90.63% | 1.31% | 43 | 7.50% | 19 | -9.52% |
30 Jun, 21 | 77 | 14.93% | 34,126,760 | 10.78% | 83.20% | 1.17% | 40 | -27.27% | 21 | 162.50% |
31 Mar, 21 | 67 | 81.08% | 30,804,832 | 33.42% | 84.43% | 1.76% | 55 | 161.90% | 8 | -11.11% |
31 Dec, 20 | 37 | 15.63% | 23,088,411 | 13.80% | 69.24% | 1.26% | 21 | -12.50% | 9 | 125.00% |
30 Sep, 20 | 32 | 77.78% | 20,288,041 | 44.53% | 74.22% | 1.63% | 24 | 200.00% | 4 | - |
30 Jun, 20 | 18 | 28.57% | 14,037,155 | -1.34% | 67.41% | 1.44% | 8 | 100.00% | 4 | - |
31 Mar, 20 | 14 | -17.65% | 14,228,404 | 2.30% | 68.34% | 1.52% | 4 | -33.33% | 4 | 300.00% |
31 Dec, 19 | 17 | 41.67% | 13,908,596 | 13.60% | 66.99% | 0.96% | 6 | -40.00% | 1 | - |
30 Sep, 19 | 12 | 71.43% | 12,243,635 | 123.37% | 83.49% | 5.98% | 10 | 400.00% | - | -100.00% |
30 Jun, 19 | 7 | - | 5,481,234 | 43.16% | 37.38% | 5.48% | 2 | - | 1 | - |
31 Mar, 19 | 7 | - | 3,828,813 | 0.00% | 26.11% | 3.83% | 2 | -33.33% | - | -100.00% |
31 Dec, 18 | 7 | - | 3,828,750 | 0.10% | 26.11% | 3.84% | 3 | -25.00% | 1 | - |
30 Sep, 18 | 7 | - | 3,825,113 | 39.11% | 26.08% | 7.42% | 4 | -42.86% | 1 | - |
30 Jun, 18 | 7 | - | 2,749,682 | - | 18.75% | - | 7 | - | - | - |
ESSA Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of ESSA Pharma's stock was made by Virsik Peter on May 06 2024, selling 694 shares at $6.95 per share (valued at $4.82K).
ESSA Pharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 1 | 3 | 33.33% |
Q1 2024 | 16 | 9 | 177.78% |
Q4 2023 | 5 | 14 | 35.71% |
Q2 2023 | - | 1 | - |
Q1 2023 | - | 8 | - |
Q4 2022 | 5 | 15 | 33.33% |
Q3 2022 | 5 | 4 | 125.00% |
Q2 2022 | 12 | 2 | 600.00% |
Q1 2022 | - | 7 | - |
Q3 2021 | 1 | 1 | 100.00% |
Q1 2021 | 1 | - | - |
Q4 2020 | 25 | 13 | 192.31% |
Q3 2009 | - | 1 | - |
Q2 2009 | 4 | 1 | 400.00% |
Q1 2009 | 3 | 6 | 50.00% |
Q4 2008 | 2 | 2 | 100.00% |
Q2 2008 | 4 | - | - |
Q1 2008 | 4 | - | - |
Q4 2007 | 1 | - | - |
Q2 2007 | 4 | - | - |
1 total buy trades, and 3 total sell trades (buy/sell ratio of 0.33%) were made by ESSA Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | 2 | - |
Q1 2024 | - | 6 | - |
Q4 2023 | 4 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 5 | 7 | 71.43% |
Q3 2022 | 5 | - | - |
Q2 2022 | 1 | 2 | 50.00% |
Q1 2022 | - | - | - |
Q3 2021 | 1 | - | - |
Q1 2021 | 1 | - | - |
Q4 2020 | - | - | - |
Q3 2009 | - | - | - |
Q2 2009 | - | - | - |
Q1 2009 | - | - | - |
Q4 2008 | - | - | - |
Q2 2008 | - | - | - |
Q1 2008 | - | - | - |
Q4 2007 | - | - | - |
Q2 2007 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of ESSA Pharma's stocks.
EPIX Ownership FAQ
Who Owns ESSA Pharma?
ESSA Pharma is owned by institutional shareholders (79.59%), insiders (2.27%), and public (18.14%). The largest institutional shareholder of ESSA Pharma is BVF INC/IL (19.78% of total shares) and the top mutual fund owner is ETFis Series Trust I (0.01% of total shares).
Who are the major institutional shareholders of ESSA Pharma?
ESSA Pharma's major institutional shareholders are BVF INC/IL, BELLEVUE GROUP AG, SOLEUS CAPITAL MANAGEMENT, L.P., MORGAN STANLEY, and PFM HEALTH SCIENCES, LP. The top five shareholders own together 63.28% of the company's share outstanding.
How many ESSA Pharma shareholders are there?
As of Jun 2024, there are 34 institutional shareholders of ESSA Pharma.
What percentage of ESSA Pharma is owned by BVF INC/IL?
BVF INC/IL owns 8.75M shares of ESSA Pharma, representing 19.78% of the company's total shares outstanding, valued at $46.02M (as of Jun 2024).
What percentage of ESSA Pharma is owned by BELLEVUE GROUP AG?
As of Jun 2024, BELLEVUE GROUP AG holds 7.89M shares of ESSA Pharma (EPIX), compromising 17.83% of the company, valued at $41.5M.
What percentage of ESSA Pharma is owned by SOLEUS CAPITAL MANAGEMENT, L.P?
SOLEUS CAPITAL MANAGEMENT, L.P is the third largest holder of ESSA Pharma. The company owns 4.21M of the company's shares outstanding (worth $22.15M).